CAS 898224-95-8

Bendamustine Impurity 6

CAS : 898224-95-8

Formule : C₁₈H₂₆ClN₃O₃

Couleur et forme : White To Off-White Solid

Masse moléculaire : 367.88

Ref: 4Z-B-4321

5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic Acid Ethyl Ester

Produit contrôlé

CAS : 898224-95-8

Stability Hygroscopic
Applications Bendamustine (B132500) impurity.

Formule : C₁₈H₂₆ClN₃O₃

Couleur et forme : Neat

Masse moléculaire : 367.87

Ref: TR-C369650

5-[(2-Chloroethyl)(2-hydroxyethyl)amino]-1-methyl-1H-benzimidazole-2-butanoic acid ethyl ester

CAS : 898224-95-8

Bendamustine is a drug that belongs to the class of alkylating agents. It is used in the treatment of cancer and chronic lymphocytic leukemia. Bendamustine is a synthetic compound, which has been shown to have oncosis (cancer-causing) properties. Bendamustine can be administered intravenously as a dry powder or in tablet form and has shown efficacy against neoplastic cells. Its mechanism of action involves binding to DNA and inhibiting the synthesis of RNA and DNA, thereby interfering with cell division. The drug also binds to erythrocytes, leading to methemoglobinemia. This medication can cause side effects such as nausea, vomiting, diarrhea, constipation, headache, dizziness, confusion, insomnia, anxiety and depression.

Formule : C₁₈H₂₆ClN₃O₃

Degré de pureté : Min. 95%

Masse moléculaire : 367.9 g/mol

Ref: 3D-YKB22495

Bendamustine Monohydroxy Acid Ethyl Ester

CAS : 898224-95-8

Formule : C₁₈H₂₆ClN₃O₃

Masse moléculaire : 367.87

Ref: ST-EA-CP-B7019